Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 19 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Renin-Angiotensin System [Clear All Filters]
Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options..
Int J Mol Sci. 20(22),
(2019). Clinical Value of Measuring the Renin/Aldosterone Levels: Optimising the Management of Uncontrolled/Resistant Hypertension..
Curr Vasc Pharmacol. 16(1), 10-14.
(2017). Global cardiovascular protection in chronic kidney disease..
Nat Rev Cardiol. 13(10), 603-8.
(2016). Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?.
J Clin Hypertens (Greenwich). 18(8), 828.
(2016). Advances in treatment of hyperkalemia in chronic kidney disease..
Expert Opin Pharmacother. 16(14), 2205-15.
(2015). Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?.
Kidney Int. 85(3), 536-46.
(2014). The authors reply..
Kidney Int. 86(4), 855.
(2014). Carotid baroreceptor stimulation: a promising approach for the management of resistant hypertension and heart failure..
Curr Vasc Pharmacol. 12(1), 30-7.
(2014). Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness..
J Am Soc Hypertens. 8(2), 74-82.
(2014). Exercise-induced platelet activation in essential hypertension: have we solved the puzzle?.
J Hypertens. 31(9), 1915-6.
(2013).
(2013). Effects of renin-angiotensin system inhibition on right ventricular function in patients with mild essential hypertension..
J Renin Angiotensin Aldosterone Syst. 12(3), 358-64.
(2011). The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia..
Clin Endocrinol (Oxf). 74(3), 306-11.
(2011). Steroids and azathioprine in the treatment of IgA nephropathy..
Clin Exp Nephrol. 15(3), 373-80.
(2011). Effects of renin-angiotensin system inhibition on left atrial function of hypertensive patients: an echocardiographic tissue deformation imaging study..
Am J Hypertens. 23(5), 556-61.
(2010). Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?.
Curr Pharm Des. 16(34), 3939-847.
(2010). Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?.
Expert Opin Pharmacother. 8(5), 529-35.
(2007). The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?.
Expert Opin Ther Targets. 11(2), 191-205.
(2007). The relationship between the sympathetic nervous system and the renin-angiotensin system in renovascular hypertension..
Acta Cardiol. 49(5), 425-34.
(1994).